William Love
Founder chez DESTINY PHARMA PLC
Fortune : 2 M $ au 31/03/2024
Postes actifs de William Love
Sociétés | Poste | Début | Fin |
---|---|---|---|
DESTINY PHARMA PLC | Director/Board Member | 01/05/2017 | - |
Chief Tech/Sci/R&D Officer | 13/04/2017 | - | |
Founder | 04/03/1996 | - | |
Chief Executive Officer | 04/03/1996 | 20/01/2017 |
Historique de carrière de William Love
Anciens postes connus de William Love
Sociétés | Poste | Début | Fin |
---|---|---|---|
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Royaume-Uni | 2 |
France | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
DESTINY PHARMA PLC | Health Technology |
Entreprise privées | 1 |
---|---|
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné. | Health Technology |
- Bourse
- Insiders
- William Love
- Expérience